Skip to main content
Top

Open Access 12-04-2024 | Hypoglycemia | Original Article

Evaluation of the possible impact of the fear of hypoglycemia on diabetes management in children and adolescents with type 1 diabetes mellitus and their parents: a cross-sectional study

Authors: Ourania Andreopoulou, Eirini Kostopoulou, Eleni Kotanidou, Sophia Daskalaki, Angeliki Vakka, Assimina Galli-Tsinopoulou, Bessie E Spiliotis

Published in: Hormones

Login to get access

Abstract

Purpose

Hypoglycemia represents a significant source of anxiety for children with type 1 diabetes mellitus (T1DM) and their caretakers. Fear of hypoglycemia (FoH) was measured in children and adolescents with T1DM as well as in their parents using an established research instrument, the Hypoglycemia Fear Survey (HFS).

Methods

This is a two-center, cross-sectional study involving 100 children and adolescents aged 6–18 years old diagnosed with T1DM. One parent of each child also participated in the study. The participants, who were recruited from two different pediatric endocrine outpatient clinics, were asked to complete the translated Greek version of the HFS, which includes one version for children (C-HFS) and one for parents (P-HFS). The association of the questionnaire responses with subjects’ characteristics, such as current age, age at diagnosis, duration of diabetes, HbA1c levels, and mode of diabetes treatment were assessed.

Results

Parents exhibited significantly higher mean HFS scores than their children. No significant correlation was found between the P-HFS or the C-HFS scores and the age of the children, duration of diabetes, HbA1c, or mode of treatment.

Conclusion

The finding that parents experience higher levels of FoH compared to their children emphasizes the importance of healthcare providers to screen parental FoH and focus on approaches to support them in order to reduce their psychological burden, thus optimizing children’s diabetes management.
Appendix
Available only for authorised users
Literature
13.
go back to reference Irvine A, Cox DJ, Gonder-Frederick L (1994) The Fear of hypoglycemia scale. In Handbook of psychology and diabetes: a guide to psychological measurement and diabetes research and practice. Edited by: Bradley C. Langhorne: Hardwood Academia Publishing; pp. 133–158 Irvine A, Cox DJ, Gonder-Frederick L (1994) The Fear of hypoglycemia scale. In Handbook of psychology and diabetes: a guide to psychological measurement and diabetes research and practice. Edited by: Bradley C. Langhorne: Hardwood Academia Publishing; pp. 133–158
24.
go back to reference Patton SR, Dolan LM, Smith LB, Thomas IH, Powers SW (2011) Pediatric parenting stress and its relation to depressive symptoms and fear of hypoglycemia in parents of young children with type 1 diabetes mellitus. J Clin Psychol Med Settings 18:345–352. https://doi.org/10.1007%2Fs10880-011-9256-1CrossRefPubMedPubMedCentral Patton SR, Dolan LM, Smith LB, Thomas IH, Powers SW (2011) Pediatric parenting stress and its relation to depressive symptoms and fear of hypoglycemia in parents of young children with type 1 diabetes mellitus. J Clin Psychol Med Settings 18:345–352. https://​doi.​org/​10.​1007%2Fs10880-011-9256-1CrossRefPubMedPubMedCentral
38.
go back to reference Anderbro T (2012) Behavior change intervention and fear of hypoglycaemia in type 1 diabetes. Karolinska Institutet Anderbro T (2012) Behavior change intervention and fear of hypoglycaemia in type 1 diabetes. Karolinska Institutet
Metadata
Title
Evaluation of the possible impact of the fear of hypoglycemia on diabetes management in children and adolescents with type 1 diabetes mellitus and their parents: a cross-sectional study
Authors
Ourania Andreopoulou
Eirini Kostopoulou
Eleni Kotanidou
Sophia Daskalaki
Angeliki Vakka
Assimina Galli-Tsinopoulou
Bessie E Spiliotis
Publication date
12-04-2024
Publisher
Springer International Publishing
Published in
Hormones
Print ISSN: 1109-3099
Electronic ISSN: 2520-8721
DOI
https://doi.org/10.1007/s42000-024-00560-z
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine